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Text
Bioactive natural products have evolved to inhibit specific cellular targets and have served as 
lead molecules for health and agricultural applications for the last century1–3. The post-
genomics era has brought a renaissance in natural product discovery using synthetic biology 
tools4–6. However, compared to traditional bioactivity-guided approaches, genome mining of 
natural products with specific and potent biological activities remains challenging4. Here we 
present the discovery and validation of a highly potent herbicide lead that targets a critical 
metabolic enzyme that is required for plant survival. Our approach is based on the 
coclustering of a self-resistance gene in the natural product biosynthetic gene cluster7–9, 
which serves as a window to potential biological activity of the encoded compound. We 
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targeted dihydroxyacid dehydratase (DHAD) in the branched-chain amino acid (BCAA) 
biosynthetic pathway in plants, the last step in this pathway often targeted for herbicide 
development10. We showed the fungal sesquiterpenoid aspterric acid (AA) discovered using 
this method is a submicromolar inhibitor of DHAD and is effective as an herbicide in spray 
applications. The self-resistance gene astD was validated to be insensitive to AA and was 
deployed as a transgene in establishment of plants that are resistant to AA. This herbicide-
resistance gene combination complements urgent efforts in overcoming weed resistance11. 
Our discovery demonstrates the potential of using a resistance-gene directed approach in 
mining of bioactive natural products.
Weeds are a major source of crop losses, and the evolution of herbicide resistance in weeds 
has led to an urgent need for new herbicides with novel modes of action11–14. The BCAAs 
biosynthetic pathway is essential for plant growth10. It is not present in animals and is 
therefore a validated target for highly specific weed control agents10. The BCAA 
biosynthetic pathway in plants is carried out by three enzymes: acetolactate synthase (ALS), 
acetohydroxy acid isomeroreductase (KARI), and DHAD (Fig. 1a). Given the success of 
targeting ALS for herbicide development11, it is surprising that no herbicide that targets 
either of the other two enzymes has been developed. DHAD which catalyzes β-dehydration 
reactions to yield α-keto acid precursors to isoleucine, valine and leucine, is an essential and 
highly conserved enzyme among plant species15,16 (Extended Data Fig. 1a and 
Supplementary Fig. 1). Efforts toward synthetic DHAD inhibitors resulted in compounds 
with submicromolar Ki; however, the compounds have no in planta activity17 (Extended 
Data Fig. 1b).
Filamentous fungi are prolific producers of natural products (NPs), many of which have 
biological activities that aid the fungi in colonizing and killing plants1,2,18. Therefore, fungal 
NPs represent a promising source of potential leads for herbicides. The abundance of 
sequenced fungal genomes enables genome mining of new NPs with novel biological 
activities4,6. Although no NP inhibitors of DHAD are known to date, we reason a fungal NP 
with this property might exist, given the indispensable role of BCAA biosynthesis in 
plants10.
To identify NP biosynthetic gene clusters that may encode a DHAD inhibitor, we 
hypothesized that such cluster must contain an additional copy of DHAD that is insensitive 
to the inhibitor, thereby providing the required self-resistance for the producing organism to 
survive. The presence of a gene encoding a self-resistance enzyme is frequently found in 
microbial NP gene clusters, as highlighted by the presence of an insensitive copy of HMGR 
or IMPDH in the gene clusters for lovastatin (that targets HMGR) or mycophenolic acid 
(that targets IMPDH), respectively (Extended Data Fig. 1c)19,20. This phenomenon has been 
used to predict molecular targets of NPs, as well as to identify gene clusters of NPs of 
known activities5,7,9.
To identify possible self-resistance enzymes, we scanned sequenced fungal genomes to 
search for colocalizations of genes encoding DHAD with core biosynthetic enzymes, such as 
terpene cyclases, polyketide synthases, etc21,22. We identified a well-conserved set of four 
genes across multiple fungal genomes (Fig. 1b), including the common soil fungus 
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Aspergillus terreus that is best known to produce lovastatin. The conserved gene clusters 
include genes that encode a sesquiterpene cyclase homolog (astA), two cytochrome P450s 
(astB and astC), and a homolog of DHAD (astD). Genes outside of this cluster are not 
conserved across the identified genomes and are hence unlikely to be involved in NP 
biosynthesis. AstD is the second copy of DHAD encoded in the genome, and is ~70% 
similar to the housekeeping copy that is well-conserved across fungi (Supplementary Fig. 2). 
Therefore, AstD is potentially a self-resistance enzyme that confers resistance to the 
encoded NP. Like a majority of biosynthetic gene clusters in sequenced fungal genomes, the 
ast cluster has not been associated with the production of a known NP4.
To identify the NP encoded by the ast cluster, we heterologously expressed astA, astB, and 
astC genes in the host Saccharomyces cerevisiae RC0123. New compounds that emerged 
were purified and their structures were elucidated with NMR spectroscopy (Supplementary 
Fig. 3 and Supplementary Table 5). RC01 expressing only astA produced a new 
sesquiterpene (1), which was confirmed to be (−)-daucane (Supplementary Fig. 4). RC01 
expressing both astA and astB led to the biosynthesis of a new product that was structurally 
determined to be the α-epoxy carboxylate (2) (Fig. 1c). When astA, astB and astC were 
expressed together, a new compound (3) became the dominant product (~ 20 mg/L). Full 
structural determination revealed the compound to be the tricyclic aspterric acid (AA), 
which is a previously isolated compound (Fig. 1c)24. The biosynthetic pathway for AA is 
therefore concise: following cyclization of farnesyl diphosphate by AstA to create the 
carbon skeleton in 1, AstB catalyzes oxidation of 1 to yield the epoxide 2. Further oxidation 
by AstC at carbon 15 yields an alcohol, which can undergo intramolecular epoxide opening 
to create AA (Fig. 1d).
Upon its initial discovery, AA was shown to have inhibitory activity towards Arabidopsis 
thaliana, however, the mode of action was not known25. Our resistance-gene directed 
approach led to rediscovery of this compound with DHAD as a potential target. We first 
confirmed that AA is able to potently inhibit A. thaliana growth in an agar-based assay (Fig. 
2a, and Supplementary Fig. 5). AA was also an effective inhibitor of root development and 
plant growth when applied to a representative monocot (Zea mays) and dicot (Solanum 
lycopersicum) (Fig. 2b). To test if AA indeed targets DHAD, we expressed and purified 
housekeeping DHAD from both A. terreus (XP_001208445.1, fDHAD) and A. thaliana 
(AT3G23940, pDHAD), as well as the putative self-resistance enzyme AstD (Supplementary 
Fig. 6). Both housekeeping DHAD enzymes converted dihydroxyisovalerate to 
ketoisovalerate (pDHAD: kcat = 1.2 sec−1, KM = 5.7 mM) as expected. The enzyme 
activities, however, were inhibited in the presence of AA (Extended Data Fig. 2). The IC50 
values of AA towards fDHAD and pDHAD were 0.31 μM and 0.50 μM at an enzyme 
concentration of 0.50 μM, respectively (Extended Data Fig. 3). AA was further determined 
to be a competitive inhibitor of pDHAD with a Ki = 0.30 μM (Extended Data Fig. 3). AA 
displayed no significant cytotoxicity towards human cell lines up to 500 μM concentration, 
consistent with the lack of DHAD in mammalian cells (Supplementary Fig. 7).
AstD catalyzes the identical β-dehydration reaction as DHAD, albeit with a significantly 
more sluggish turnover rate (kcat = 0.03 sec−1, KM = 5.4 mM). However, the enzyme was not 
inhibited by AA, even at the solubility limit of 8 mM (Extended Data Fig. 3). To determine 
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if AstD can confer resistance to AA-sensitive strains, we developed a yeast based assay. The 
genome copy of DHAD encoded by ILV3 was first deleted from Saccharomyces cerevisiae 
strain DHY ΔURA3, which resulted in an auxotroph that requires exogenous addition of Ile, 
Leu and Val to grow. We then introduced either fDHAD or astD episomally, both of which 
allowed the strain to grow in the absence of the three BCAAs (Extended Data Fig. 4). 
However, yeast expressing fDHAD was approximately 100 times more sensitive to AA 
(IC50 of 2 μM) compared to yeast expressing AstD (IC50 of 200 μM) (Fig. 2c). Collectively, 
the biochemical and genetic assays validated AA as the first natural product inhibitor of 
fungal and plant DHAD; and AstD serves as the self-resistance enzyme in the ast 
biosynthetic gene cluster.
The (R)-α-hydroxyacid and (R)-configured β-ether oxygen moieties in AA mimic the (2R, 
3R)-dihydroxy groups present in natural substrates such as dihydroxyisovalerate. The β-
ether oxygen in AA is in position to coordinate to the 2Fe-2S cluster that is a required 
cofactor in both fungal and plant DHAD16,17. To understand potential AA mechanism of 
action, we determined the crystal structure (2.11 Å) of the pDHAD complexed with 2Fe-2S 
cluster (holo-pDHAD) (Fig. 2d, Extended Data Fig. 5, and Extended Data Table 1). We 
identified a binding chamber at the homodimer interface, similar to that found in the holo 
bacterial L-arabinonate dehydratase26 (Fig. 2d). The interior of the chamber is positively 
charged (2Fe-2S and Mg2+) while the entrance is lined with hydrophobic residues. The 
modeled binding mode of α,β-dihydroxyisovalerate and AA predicted by computational 
docking are shown in Fig. 2e. The pocket is sufficiently spacious to accommodate the 
bulkier AA, and provide stronger hydrophobic interactions than the native substrate with a 
5.3 ± 0.3 kcal/mol gain in binding energy (Fig. 2e). Base on the holo-pDHAD structure, we 
constructed a homology model of AstD to determine potential mechanism of resistance 
(Extended Data Fig. 5 and 6). Comparison of pDHAD and the modeled AstD structures 
shows that while most of the residues in the catalytic chamber are conserved, the 
hydrophobic region at the entrance to the reactive chamber in AstD is more constricted as a 
result of two amino acid substitutions (V496L and I177L). Narrowing of the entrance could 
therefore sterically exclude the bulkier AA from binding in the active site, while the smaller, 
natural substrates are still able to enter the chamber.
To explore the potential of AA as an herbicide, we performed spray treatment of A. thaliana 
with AA. We added AA into a commercial glufosinate formulation known as Finale® at a 
final AA concentration of 250 μM27,28. We then sprayed AA solution onto glufosinate 
resistant A. thaliana. Finale® alone had no observable inhibitory effects on plant growth, but 
adding AA severely inhibited plant growth (Extended Data Fig. 7). In addition, A. thaliana 
plants treated with AA before flowering failed to form normal pollen, which was also 
observed previously25. We found that the pistil of treated plants could still be successfully 
pollinated using healthy pollen from the untreated A. thaliana, indicating that AA 
preferentially affects pollen but not egg formation (Extended Data Fig. 8 and 9). This effect 
was also observed with a lower concentration of AA (100 μM). Thus, in addition to its 
herbicidal properties, AA could potentially be used as a chemical hybridization agent for 
hybrid seed production29.
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We next investigated whether plants expressing astD are resistant to AA. This was motivated 
by the successful combination of glyphosate and genetically modified crops that are 
selectively resistant to glyphosate (Roundup Ready®)30. The A. terreus astD gene was 
codon optimized and the N-terminus was fused to a chloroplast localization signal derived 
from pDHAD. Wild type or astD transgene-expressing A. thaliana was then grown on media 
that contained 100 μM AA. In the presence of AA, the growth of wild-type plants was 
strongly inhibited, and arrested at the cotyledon stage (Fig. 3a). In contrast, the growth of 
astD transgenic plants was relatively unaffected by AA, as indicated by the normally 
expanded rosette leaves, elongated roots, and whole plant fresh weight (Fig. 3a and b). The 
expression of AstD was verified by western blot (Supplementary Fig. 8). A spray assay was 
also performed using T2 astD transgenic A. thaliana plants, which showed no observable 
growth defects under such treatment (Fig. 3c). In contrast, the control plants carrying the 
empty vector showed a strong growth inhibitory phenotype when treated with AA (Fig. 3c). 
Quantitative measurements of plant height showed AstD effectively confers AA resistance to 
A. thaliana (Fig. 3d).
In summary, resistance-gene directed discovery of NPs in the fungus A. terreus led to the 
discovery of a natural herbicide AA and the determination of its mode of action. In addition, 
introducing astD as a transgene or editing the sequence of the plant DHAD endogenous gene 
could be used to create AA-resistant crops. We suggest that AA is a promising lead for the 
development as a broad spectrum commercial herbicide.
METHODS
General materials and methods
Biological reagents, chemicals, media and enzymes were purchased from standard 
commercial sources unless stated. Plant, fungal, yeast and bacterial strains, plasmids and 
primers used in this study are summarized in Supplementary Tables 3, 4 and 5. DNA and 
RNA manipulations were carried out using Zymo ZR Fungal/Bacterial DNA Microprep™ kit 
and Invitrogen Ribopure™ kit respectively. DNA sequencing was performed at Laragen, Inc. 
The primers and codon optimized gblocks were synthesized by IDT, Inc.
Expression of ast genes in Aspergillus nidulans for cDNA isolation
Plasmids pYTU, pYTP, pYTR digested with PacI and SwaI were used as vectors to insert 
genes31. A gpda promoter was generated by PCR amplification using primers Gpda-pYTU-
F and Gpda-R with pYTR serving as template. Genes to be expressed were amplified 
through PCR using the genomic DNA of Aspergillus terreus NIH2624 as a template. A 4.5 
kb fragment obtained using primers AstD-pYTU-recomb-F and AstA-pYTU-recomb-R was 
cloned into pYTU together with a gpda promoter by yeast homologous recombination to 
obtain pAstD+AstA-pYTU. Yeast transformation was performed using Frozen-EZ Yeast 
Transformation II Kit™ (Zymo Research). A 2.4 kb fragment obtained using primers AstB-
pYTR-recomb-F and AstB-pYTR-recomb-R was cloned into pYTR by yeast homologous 
recombination to obtain pAstB-pYTR. Similarly, a 2.3 kb fragment obtained using primers 
AstC-pYTP-recomb-F and AstC-pYTP-recomb-R was cloned into pYTP by yeast 
homologous recombination to obtain pAstC-pYTP.
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All three plasmids (pAstD+AstA-pYTU, pAstB-pYTR and pAstC-pYTP) were transformed 
into A. nidulans following standard protocols to result in the A. nidulans strain TY0131. 
TY01 was cultured in liquid CD-ST medium (20 g/L starch, 20 g/L peptone, 50 mL/L nitrate 
salts and 1 mL/L trace elements) at 28°C for 3 days. Total RNA of TY01 was extracted with 
the Invitrogen Ribopure™ kit, and total cDNA of TY01 was obtained using the SuperScript 
III reverse transcriptase kit (Thermo Fisher Scientific). The cDNA fragment of astA was 
PCR amplified using primers AstA-xw55-recomb-F and AstA-xw55-recomb-R. The cDNA 
fragment of astB was PCR amplified using primers AstB-xw06-recomb-F and AstB-xw06-
recomb-R. The cDNA fragment of astC was PCR amplified using primers AstC-xw02-
recomb-F and AstC-xw02-recomb-R. The cDNA fragment of astD was PCR amplified using 
primers AstD-pXP318-F and AstD-pXP318-R. All the introns were confirmed to be 
correctly removed by sequencing.
Construction of Saccharomyces cerevisiae strains
Plasmid pXW55 (URA3 marker) digested with NdeI and PmeI was used to introduce the 
astA gene23. A 1.3 kb fragment containing astA obtained from PCR using primers AstA-
xw55-recomb-F and AstA-xw55-recomb-R was cloned into pXW55 using yeast 
homologous recombination to afford pAstA-xw55. The plasmid pAstA-xw55 was then 
transformed into Saccharomyces cerevisiae RC01 to generate strain TY0223.
Plasmid pXW06 (TRP1 marker) digested with NdeI and PmeI was used to introduce the 
astB gene23. A 1.6 kb fragment containing astB obtained from PCR using primers AstB-
xw06-recomb-F and AstB-xw06-recomb-R were cloned into pXW06 using yeast 
homologous recombination to afford pAstB-xw06. The plasmid pAstB-xw06 was then 
transformed into TY02 to generate strain TY03.
Plasmid pXW06 (LEU2 marker) digested with NdeI and PmeI was used to introduce the 
astC gene23. A 1.6 kb fragment containing astC obtained from PCR using primers AstC-
xw02-recomb-F and AstC-xw02-recomb-R were cloned into pXW02 using yeast 
homologous recombination to afford pAstC-xw02. The plasmid pAstC-xw02 was then 
transformed into TY03 to generate strain TY04.
URA3 gene was inserted into ilv3 locus of Saccharomyces cerevisiae DHY ΔURA3 strain to 
generate UB01. A 879 bp homologous recombination donor fragment with 35–40 bp 
homologous regions flanking ilv3 ORF was amplified using primers ILV3p-URA3-F and 
ILV3t-URA3-R using yeast gDNA as template. The PCR product was gel purified and 
transformed into Saccharomyces cerevisiae DHY ΔURA3, and selected on uracil dropout 
media to give UB01. The resulting strain was subjected to verification by colony PCR with 
primers ILV3KO-ck-F and ILV3KO-ck-R and the amplified fragment was sequence 
confirmed.
The URA3 gene inserted into ilv3 locus of Saccharomyces cerevisiae DHY ΔURA3 was 
deleted from UB01 using homologous recombination to generate UB02. A 150 bp 
homologous recombination donor fragment with 75 bp homologous regions flanking ilv3 
ORF was amplified using primers ILV3KO-F and ILV3KO-R, gel purified and transformed 
into UB01, and counterselected on 5-fluoroorotic acid (5-FoA) containing media to give 
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UB02. The resulting strain was subjected to verification by colony PCR with primers 
ILV3KO-ck-F and ILV3KO-ck-R and the amplified fragment was sequenced confirmed.
The empty plasmid pXP318 (URA3 marker) was transformed into UB02 to generate 
TY0532.
Plasmid pXP318 digested with SpeI and XhoI was used as vector to introduce gene 
encoding fDHAD32. The cDNA of Aspergillus terreus NIH 2624 served as template for PCR 
amplification. A 1.7 kb fragment obtained using primers fDHAD-pXP318-F and fDHAD-
pXP318-R were cloned into pXP318 using yeast homologous recombination to afford 
fDHAD-pXP318. Then, fDHAD-pXP318 was transformed into UB02 to generate TY06. 
fDHAD was driven by a constitutive promoter TEF1.
Plasmid pXP318 digested with SpeI and XhoI was used as vector to introduce astD gene32. 
The cDNA isolated from TY01 served as the template for PCR amplification. A 1.8 kb 
fragment obtained using primers AstD-pXP318-F and AstD-pXP318-R were cloned into 
pXP318 using yeast homologous recombination to give AstD-pXP318. A FLAG-tag was 
also add to the N-terminal of AstD. Then, AstD-pXP318 was transformed into UB02 to 
generate TY07. AstD was driven by a constitutive promoter TEF1.
Fermentation and compound analyses and isolation
A seed culture of S. cerevisiae strain was grown in 40 mL of synthetic dropout medium for 2 
d at 28°C, 250 rpm. Fermentation of the yeast was carried out using YPD (yeast extract 10 
g/L, peptone 20 g/L) supplement with 2% dextrose for 3 d at 28°C, 250 rpm.
HPLC-MS analyses were performed using a Shimadzu 2020 EVLC-MS (Phenomenex® 
Luna, 5μ, 2.0 × 100 mm, C-18 column) using positive and negative mode electrospray 
ionization. The elution method was a linear gradient of 5–95% (v/v) acetonitrile/water in 15 
min, followed by 95% (v/v) acetonitrile/water for 3 min with a flow rate of 0.3 mL/min. The 
HPLC buffers were supplemented with 0.05% formic acid (v/v). HPLC purifications were 
performed using a Shimadzu Prominence HPLC (Phenomenex® Kinetex, 5μ, 10.0 × 250 
mm, C-18 column). The elution method was a linear gradient of 65–100% (v/v) acetonitrile/
water in 25 min, with a flow rate of 2.5 mL/min. GC-MS analyses were performed using 
Agilent Technologies GC-MS 6890/5973 equipped with a DB-FFAP column. An inlet 
temperature of 240°C and constant pressure of 4.2 psi were used. The oven temperature was 
initially at 60°C and then ramped at 10°C/min for 20 min, followed by a hold at 240°C for 5 
min.
To isolate compound 1, the fermentation broth of TY02 was centrifuged (5000 rpm, 10 min), 
and cell pellet was harvested and soaked in acetone. The organic phase was dried over 
sodium sulfate, concentrated to oil form, and subjected to silica column purification with 
hexane. To isolate compound 2, the fermentation broth of TY03 was centrifuged (5000 rpm, 
10 min), and supernatant was extracted three times with ethyl acetate. The organic phase 
was dried over sodium sulfate, concentrated to oil form, and then and subjected to HPLC 
purification. To isolate compound AA, the fermentation broth of TY04 was centrifuged 
(5000 rpm, 10 min), and supernatant was extracted three times with ethyl acetate. The 
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organic phase was dried over sodium sulfate, concentrated to oil form, and subjected to 
HPLC purification.
Structure determination of compounds
Compound 1, colorless oil readily dissolved in hexane and chloroform, had a molecular 
formula C15H24, as deduced from EI-MS [M]+ m/z 204, and showed [α]D22 = − 30° (n-
hexane; c = 0.1). GC-MS 70 eV, m/z (relative intensity): 204 [M]+ (42), 189 (5), 161 (35), 
136 (100), 133 (10), 121 (70), 119 (25), 107 (20), 105 (27), 93 (21), 91 (26), 79 (13), 77 
(15), 69 (20), 55 (12), 43 (12), 41 (13), 38 (21); 1H NMR (500 MHz, CDCl3): δ 5.37 (1H, 
m), 2.20-2.10 (5H, m), 2.10-2.00 (2H, m), 1.95 (1H, d, 15.3), 1.75 (3H, s), 1.71 (3H, q, 1.7), 
1.61 (3H, brs), 1.44 (1H, dd, 11.4, 7.2), 1.36 (1H, m), 1.31 (1H, dd, 11.3, 2.6), 0.73 (3H, s); 
13C NMR (125 MHz, CDCl3): δ 138.4, 138.3, 122.4, 122.2, 57.4, 42.6, 41.4, 40.3, 34.5, 
29.6, 27.3, 25.0, 23.3, 20.6, 19.2. Both of the NMR and MS spectrums are identical to a 
known compound (+)-daucane, however, the optical rotation is opposite which led to the 
assignment of 1 to be (−)-daucane33.
Compound 2, colorless oil readily dissolved in ethyl acetate and chloroform, had a 
molecular formula C15H22O3, as deduced from LC-MS [M+H]+ m/z 251, [M-H]− m/z 249. 
1H NMR (500 MHz, CDCl3): δ 8.09 (1H, brs), 3.25 (1H, t, 7.4), 2.71 (1H, dd, 14.6, 6.5), 
2.48 (1H, dd, 14.8, 6.3), 2.36 (1H, dd, 14.0, 6.6), 2.26 (1H, m), 2.15 (1H, dd, 16.3, 8.9), 2.08 
(1H, d, 12.0), 1.84 (1H, q, 13.1), 1.73 (3H, d, 2.3), 1.59 (3H, d, 2.2), 1.48~1.35 (3H, m), 
1.31 (1H, td, 11.5, 9.0), 0.86 (3H, s). 13C NMR (125 MHz, CDCl3): δ 176.0, 135.8, 123.2, 
60.1, 59.8, 59.4, 44.1, 40.5, 38.8, 30.6, 29.3, 24.9, 23.8, 20.6, 17.8.
Compound 3 is a colorless oil readily dissolved in acetone and chloroform, had a molecular 
formula C15H22O4, as deduced from LC-MS [M+H]+ m/z 267, [M-H]− m/z 265. 1H NMR 
(500 MHz, CDCl3): δ 4.29 (1H, d, 8.5), 3.92 (1H, d, 8.3), 3.48 (1H, d, 8.3), 2.42 (1H, dd, 
14.9, 7.3), 2.37~2.28 (2H, m), 2.25 (1H, dd, 13.0, 4.4), 2.20~2.17 (1H, m), 2.12 (1H, d, 
13.4), 2.01 (1H, m), 1.80~1.65 (2H, m), 1.71 (3H, s), 1.64~1.54 (1H,m), 1.60 (3H, s), 1.50 
(1H, m); 13C NMR (125 MHz, CDCl3): δ 178.2, 134.5, 125.2, 82.9, 76.3, 75.6, 55.4, 53.0, 
36.6, 36.2, 33.8, 32.2, 23.6, 23.4, 20.9. 3 is identical to aspterric acid (AA) as reported24,25.
Protein expression, purification and biochemical assay
To express and purify pDHAD, primers pDHAD-pET-F and pDHAD-pET-R were used to 
amplify a 1.7 kb DNA fragment containing pdhad (AT3G23940). The PCR product was 
cloned into pET28a using NheI and NotI restriction sites. The resulting plasmid pDHAD-
pET was transformed into E.coli BL21 (DE3) to give TY08. To express and purify fDHAD 
(XP_001208445.1), primers fDHAD-pET-F and fDHAD-pET-R were used to amplify a 1.6 
kb DNA fragment containing fdhad. The PCR product was cloned into pET28a using NdeI 
and NotI restriction sites. The resulted plasmid fDHAD-pET was transformed into E. coli 
BL21 (DE3) to obtain TY09. To express and purify AstD (XP_001213593.1), primers AstD-
pET-F and AstD-pET-R were used to amplify a 1.6 kb DNA fragment containing astD. The 
PCR product was cloned into pET28a using NdeI and NotI restriction sites. The resulted 
plasmid AstD-pET was transformed into E. coli BL21 (DE3) to obtain TY10. All DHADs 
fused a 6×His-tag with a molecular weight ~62 kD were expressed at 16°C 220 rpm for 20 h 
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after 100 μM IPTG induction (IPTG was added when OD600 = 0.8). Cells of 1 L culture 
were then harvested by centrifugation at 5000 rpm at 4°C. Cell pellet was resuspended in 15 
mL Buffer A10 (20 mM Tris-HCl pH 7.5, 50 mM NaCl, 8% glycerol, 10 mM imidazole). 
The cells were lysed by sonication, and the insoluble material was sedimented by 
centrifugation at 16000 rpm at 4°C. The protein supernatant was then incubated with 3 mL 
Ni-NTA for 4 h with slow, constant rotation at 4°C. Subsequently the Ni-NTA resin was 
washed with 10 column volumes of Buffer A50 (Buffer A + 50 mM imidazole). For elution 
of the target protein, the Ni-NTA resin was incubated for 10 min with 6 mL Buffer A300 
(Buffer A + 300 mM imidazole). The supernatant from the elution step was then analyzed by 
SDS-PAGE together with the supernatants from the other purification steps. The elution 
fraction containing the recombinant protein was buffer exchanged into storage buffer (50 
mM Tris-HCl pH 7.2, 50 mM NaCl, 10 mM MgCl2, 10% glycerol, 5 mM DTT, 5 mM 
GSH).
In vitro activity assays were carried out in 50 μL reaction mixture containing storage buffer, 
10 mM (±)-sodium α,β-dihydroxyisovalerate hydrate (4) and 0.5 μM of purified DHAD 
enzyme. The reaction was initiated by adding the enzyme. After 0.5 h incubation at 30°C, 
the reactions were stopped by adding equal volume of ethanol. Approximately 0.1 volume of 
100 mM phenylhydrazine (PHH) was added to derivatize the product 3-methyl-2-oxo-
butanoic acid (5) into 6 at room temperature for 30 min. 20 μL of the reaction mixture was 
subject to LC-MS analysis. The area of the HPLC peak with UV absorption at 350 nm were 
used to quantify the amount of 6. (Extended Data Fig. 2).
The inhibition percentage of AA on DHADs determined using in vitro biochemical assays 
are calculated by following equation:
inhibition percentage = 1 − initial reaction ratewithAAinitial reaction ratewithoutAA
Growth inhibition assay of S. cerevisiae on plates or in the tubes
S. cerevisiae was grown in isoleucine, leucine and valine (ILV) dropout media (20 g/L 
glucose, 0.67 g/L Difco™ Yeast Nitrogen Base w/o amino acids, 18 mg/L adenine, arginine 
76 mg/L, asparagine 76 mg/L, aspartic acid 76 mg/L, glutamic acid 76 mg/L, histidine 76 
mg/L, lysine 76 mg/L, methionine 76 mg/L, phenylalanine 76 mg/L, serine 76 mg/L, 
threonine 76 mg/L, tryptophan 76 mg/L, tyrosine 76 mg/L) to test growth inhibition of AA 
on S. cerevisiae. S. cerevisiae was incubated at 28°C until OD600 of the control strain 
without AA treatment reached about 0.8. The ratio of yeast OD600 in media with AA 
treatment to yeast OD600 in media without AA was calculated as the percentage of growth 
inhibition. The inhibition curve was plotted as percentage of inhibition versus AA 
concentrations. To further prove AA affects BCAA biosynthesis, isoleucine, leucine and 
valine was also complemented to the media with or without treatment of AA. The growth 
curves of TY05, TY06 and TY07 were also plotted in Extended Data Fig. 4. The OD600 was 
recorded for every 20 min over a total of 50 h. Percent inhibition. The growth inhibition 
percentage of AA on S. cerevisiae strain is calculated by dividing the cell density (OD600) of 
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the AA-treated strain to the corresponding untreated strains when OD600 reaches ~ 0.8 using 
following equation:
growth inhibition percentage = 1 −
OD600 of AA treated strain
0.8
in which 0.8 is the OD600 of untreated strain.
Growth inhibition assay of plants on plates or in the tubes
MS (2.16 g/L Murashige and Skoog basal medium, 8 g/L sucrose, 8 g/L agar) media was 
used to test the growth inhibition of AA on A. thaliana, Solanum lycopersicum, and Zea 
mays. A. thaliana, S. lycopersicum, and Z. mays were grown under long day condition (16/8 
h light/dark) using cool-white fluorescence bulbs as the light resource at 23°C. AA was 
dissolved in ethanol and added to the media before inoculating strains or growing plants. 
The media of control treatment contains the same amount of ethanol, but without AA.
Plant growth inhibition assay by spraying
AA was firstly dissolved in ethanol and then added to solvent (0.06 g/L Finale® Bayer Inc. 
+ 20 g/L EtOH). The control plants were treated with solvent containing ethanol only. A. 
thaliana that are resistant to glufosinate (containing the bar gene) were grown under long day 
condition (16/8 h light/dark) using cool-white fluorescence bulbs as the light resource at 
23°C. Spraying treatments began upon the seed germination, and was repeated once every 
two days with approximately 0.4 mL AA solution per time per pot.
Structure determination of holo-pDHAD
The gene encoding pDHAD (residues 35–608) was cloned into pET21a derivative vector 
pSJ2 with an eight histidine (8×His) tag and a TEV protease cleavage site at the N-terminus. 
The following primers were used for cloning: the forward primer DHAD-F and the reverse 
primer DHAD-R. The double mutant K559A/K560A for efficient crystallization was 
designed using the surface entropy reduction prediction (SERp) server34. Mutations were 
generated by PCR using the forward primer K559AK560A-F and reverse primer 
K559AK560A-R. All constructed plasmids were verified by DNA sequencing.
pDHAD purified under aerobic conditions was found to contain no iron-sulfur cluster (apo 
form). Hence we performed [2Fe-2S] Cluster reconstitution under the atmosphere of 
nitrogen in an anaerobic box. The protein was incubated with FeCl3 at the ratio of 1:10 for 1 
h on ice and then 10 equivalents of Na2S per protein was added drop-wise every 30 min for 
3 h. The reaction mixture was then incubated overnight. Excess FeCl3 and Na2S were 
removed using a SephadexTM G-25 Fine column (GE Healthcare)26.
The reconstituted holo-pDHAD was crystallized in an anaerobic box. The proteins (at 10 
mg/mL) were mixed in a 1:1 ratio with the reservoir solution in a 50 μL volume of 2 μL and 
equilibrated against the reservoir solution, using the sitting-drop vapor diffusion method at 
16°C. Crystals for diffraction were observed in 0.1 M sodium acetate pH 5.0, 1.5 M 
ammonium sulfate after 5 d.
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All crystals were flash-cooled in liquid nitrogen after cryo-protected with solution 
containing 25% glycerol, 1.5 M ammonium sulfate, 0.1 M sodium acetate pH 5.0. The data 
were collected at 100K and at the Beam Line 19U1 in Shanghai Synchrotron Radiation 
Facility (SSRF). Diffraction data of holo-pDHAD was collected at the wavelength of 
0.97774 Å. The best crystals diffracted to a resolution of 2.11 Å. The Ramachandran plot 
favored (%), allowed (%) and outlier (%) are 98.05, 1.60, and 0.36 respectively. All data sets 
were indexed, integrated, and scaled using the HKL3000 package35. The crystals belonged 
to space group P42212. The statistics of the data collection are summarized in Extended Data 
Table 1.
The holo-pDHAD structure was solved by the molecular replacement method Phaser 
embedded in the CCP4i suite and the L-arabinonate dehydratase crystal structure (PDB_ID: 
5J83) as the search model. All the side chains were removed during the molecular 
replacement process36,37. The resulting model were refined against the diffraction data using 
the REFMAC5 program of CCP4i38. Based on the improved electron density, the side chains 
of holo-pDHAD protein, iron sulfur cluster, water molecule, acetate ion, sulfate ions, and 
magnesium ion were manually built using the program WinCoot39. The Rwork and Rfree 
values of the structure are 17.67% and 22.15%, respectively. The detailed refinement 
statistics are summarized in Extended Data Table 1. The geometry of the model was 
validated by WinCoot. Structural factor and coordinate of holo-pDHAD have been deposited 
in the Protein Bank (PDB code: 5ZE4).
Homology modelling of AstD and docking of substrate or AA into active site of holo-
pDHAD
The structure of holo-pDHAD was prepared in Schrodinger suite software under OPLS3 
force field40. Hydrogen atoms were added to reconstituted crystal structures according to the 
physiological pH (7.0) with the PROPKA tool in Protein Preparation tool in Maestro to 
optimize the hydrogen bond network26,41. Constrained energy minimizations were 
conducted on the full-atomic models, with heavy atom coverage to 0.5 Å. The homology 
model was performed in Modeller 9.1842, using the crystal structure of holo-pDHAD solved 
in this work as a template. Sequence alignment in Modeller indicated that AstD and pDHAD 
shared 56.8% sequence identity and 75.0% sequence similarity (Extended Data Fig. 6). All 
the highly conserved residues and motifs were properly aligned. A total of 2000 models 
were generated for each target in Modeller with the fully annealed protocol. The optimal 
models were chosen for docking studies according to DOPE (Discrete Optimized Protein 
Energy) score.
All ligand structures were built in Schrodinger Maestro software26. The LigPrep module in 
Schrodinger software was introduced for geometric optimization by using OPLS3 force 
field40. The ionization state of ligands were calculated with Epik tool employing Hammett 
and Taft methods in conjunction with ionization and tautomerization tools43. The docking of 
a ligand to the receptor was performed using Glide44. We included cofactors observed in 
crystal structure during the docking. Since both water and SO42− occupied the catalytic site, 
they were excluded prior to docking. Cubic boxes centered on the ligand mass center with a 
radius 8 Å for all ligands defined the docking binding regions. Flexible ligand docking was 
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executed for all structures. Ten poses per ligand out of 20,000 were included in the post-
docking energy minimization. The best scored pose for the ligand was chosen as the initial 
structure for further study. The MM/GBSA method was introduced to evaluate the ligand 
binding affinity based on the best scored docking pose in Schrodinger software. Figures are 
prepared in PyMOL and Inkscape45,46. Both of native substrate α,β-dihydroxyisovalerate 
and AA were docked into the catalytic site of pDHAD. The cross-section electrostatic 
surface map shows this unique catalytic pocket has a positively charged internal and a 
hydrophobic entrance, which binds to negatively charged “head” and hydrophobic “tail” of 
substrate or AA respectively. Thus the negatively charged “head” can lead both of the 
substrate and AA into the catalytic chamber. The bulky hydrophobic tricyclic moiety of AA, 
however, provides stronger hydrophobic interactions to the entrance and blocks the entrance 
of active site due to the hydrophobic residues at the entrance, including G68, A71, I72, I134, 
A133, M141, V212, F215, M498 and P501. In contrast, the smaller “tail” of native substrate 
provides less interactions to entrance because the smaller size limits efficient hydrophobic 
contact to nearby residues. This implies that once AA binds to pDHAD, it can prevent 
substrate approaching the active site. We also introduced molecular mechanics generalized 
Born and surface area (MM/GBSA) continuum solvation method, an widely used approach 
for relative binding energy calculation, to evaluate the relative binding affinity for both 
ligands47. The MM/GBSA calculations had been done in Prime48 (Schrödinger 2015 suite). 
The MM/GBSA energy was calculated using following equation:
ΔGbind = Ecomplex − Eprotein − Eligand
E denotes energy and includes terms such as protein–ligand van der Waals contacts, 
electrostatic interactions, ligand desolvation, and internal strain (ligand and protein) 
energies, using VSGB2.0 implicit solvent model with the OPLS2005 force field. The solvent 
entropy is also included in the VSGB2.0 energy model, as it is for other Generalized Born 
(GB) and Poison–Boltzmann (PB) continuum solvent models.
MM/GBSA calculation shows that the relative binding energy for AA and α,β-
dihydroxyisovalerate is −18.6 ± 0.3 kcal/mol and −13.3 ± 0.2 kcal/mol respectively, which 
shows the binding constant of AA to active site is about 6000 times greater than α,β-
dihydroxyisovalerate. This further confirms that AA is a competitive inhibitor of pDHAD.
Cytotoxicity assay of AA
Cell proliferation experiments were performed in a 96-well format (five replicates per 
sample) using melanoma cell line A375 and SK-MEL-1. AA treatments were initiated 24 h 
postseeding for 72 h, and cell survival was quantified using CellTiter-GLO assay (Promega).
Cross experiment of A. thaliana
To make male sterile A. thaliana, AA was added to chemical hybridization agent (CHA) 
formulation (250 μM AA, 2% ethanol, 0.1% Tween-80, 1% corn oil in water), which has 
less inhibition effect on the growth of A. thaliana. Flowers of the AA treated col-0 were 
selected as the female parent. The non-treated A. thaliana containing a glufosinate resistant 
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gene were used as male parent to donate pollen. 2-week old F1 progeny resulting from the 
cross were treated by Finale (11.3% glufosinate-ammonium) at 1:2000 dilution. The results 
are summarized in Extended Data Fig. 9.
Construction of the transgenic plants
The coding sequence of AstD was codon optimized for A. thaliana. A chloroplast 
localization signal (CLS) of 35-amino acid residues derived from the N-terminal of A. 
thaliana DHAD (MQATIFSPRATLFPCKPLLPSHNVNSRRPSIISCS) was fused to N-
terminus of the codon optimized AstD. A 3×FLAG-tag was inserted between the CLS and 
the codon optimized AstD (Supplementary Table 6). The gene block containing CLS, 
FLAG-tag and astD was synthesized and then cloned into pEG202 vector using Gateway LR 
Clonase II Enzyme Mix (ThermoFisher scientific). The original CaMV 35S promoter of 
pEG202 was substituted by Ubiquitin-10 promoter to drive the expression of AstD. The 
construct was electro-transformed into Agrobacterium tumefaciens strain Agl0 followed by 
A. thaliana transformation using the standard floral dip method49. The A. thaliana Col-0 
ecotype was transformed. Positive transgenic plants were selected using the glufosinate 
resistance marker, and were tested for survival in presence of AA.
Protein expression verification with western blot
Approximately 0.5 gram of leaf tissue of transgenic A. thaliana was grounded in liquid 
nitrogen. Proteins were homogenized in 2× SDS buffer followed by 5-min centrifuge at 
21,000 g to remove undissolved debris. The supernatant containing resolved proteins were 
loaded onto a 4–12% Bis-Tris gel, and separated using MOPS running buffer. Transfer was 
conducted using iBlot2 dry transfer device and PVDF membrane. The total proteins were 
stained with Ponceau to demonstrate equal loading. Western blotting was performed using 
Sigma monoclonal anti-FLAG M2-Peroxidase antibody, followed by detection using 
Amersham ECL Prime detection reagent.
Data availability
The data that support the findings of this study are available within the paper and its 
Supplementary Information, or are available from the corresponding authors upon 
reasonable request.
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Extended Data
Extended Data Figure 1. The rationale of resistance-gene directed discovery of a natural 
herbicide with new mode of action
a, Phylogenetic tree of DHAD among bacteria, fungi and plants. The evolutionary history 
was inferred by using the Neighbor-Joining method (MEGA7). Units represent the number 
of amino acid substitutions per site. b, Representatives of small molecules that inhibit 
DHAD in vitro, but fail to inhibit plant growth. c, Examples of co-localization of 
biosynthetic gene clusters (BGCs) and targets. The biosynthetic core genes are shown in 
blue and the self-resistance enzymes (SREs) are shown in red. The blockbuster cholesterol-
lowering lovastatin drug targets HMG-CoA reductase (HMGR) in eukaryotes. In the fungus 
Aspergillus terreus that produces lovastatin, a second copy of HMGR encoded by ORF8 is 
present in the gene cluster (top). BGC of the immunosuppressant mycophenolic acid from 
Penicillium sp. contains a second copy of inosine monophosphate dehydrogenase (IMPDH), 
which represents the SRE to this cluster (bottom).
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Extended Data Figure 2. Biochemical assays of DHAD functions
a, Assaying DHAD activities in converting the dihydroxyacid 4 into the α-ketoacid 5. 
Formation of 5 can be detected on HPLC by chemical derivatization using phenylhydrazine 
(PHH) to yield 6. b, LC-MS traces of the biochemical assays of A. thaliana DHAD 
(pDHAD). Extracted ion chromatogram (EIC) of positive ion mass of [M+H]+=207 is 
shown in red. i. The derivatization reaction was validated by using the authentic 5. ii. The 
bioactivity of pDHAD in converting 4 into 5 was validated. iii. Addition of DMSO to 
pDHAD enzymatic reaction mixture has no effect. iv. Addition of 10 μM AA to the reaction 
mixture abolished pDHAD activity. The experiments were repeated independently for 3 
times with similar results.
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Extended Data Figure 3. Inhibition assay of different DHADs using AA
Three DHAD enzymes were assayed, including pDHAD (plant DHAD from A. thaliana), 
fDHAD (fungal housekeeping DHAD from A. terreus) and AstD (DHAD homolog within 
ast cluster). IC50 and Ki values of AA were measured based on inhibition percentage at 
different AA concentrations. Center values are averages, errors bars are s.d.; n = 3 
biologically independent experiments. a, Plot of the inhibition percentage of 0.5 μM fDHAD 
as a function of AA concentration. b, Plot of the inhibition percentage of 0.5 μM pDHAD as 
a function of AA concentration. c, Plot of the inhibition percentage of 0.5 μM AstD as a 
function of AA concentration. d, Analysis of inhibitory kinetics of AA on pDHAD using the 
Lineweaver-Burk method at different concentrations of AA (left). Linear fitting of apparent 
Michaelis constant (KM,app) as a function of AA concentration yields the inhibition constant 
(Ki) of AA on pDHAD (right).
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Extended Data Figure 4. Growth curve of S. cerevisiae ΔILV3 expressing AstD and fDHAD
The genome copy of DHAD encoded by ILV3 was first deleted from Saccharomyces 
cerevisiae strain DHY ΔURA3 to give UB02. UB02 was then either chemically 
complemented by growth on ILV (leucine, isoleucine and valine)-containing media or 
genetically by expressing of fDHAD or AstD episomally (TY06 or TY07, respectively). The 
empty vector pXP318 was also transformed into UB02 to generate a control strain TY05. 
The optical density of cell growth under different conditions were plotted as a function of 
time. Center values are averages, errors bars are s.d.; n = 3 biologically independent 
experiments. a, Growth curve in ILV dropout media with no AA. b, Growth curve in ILV 
dropout media with 125 μM AA. c, Growth curve in ILV supplemented media; d, Growth 
curve in ILV supplemented media with 250 μM AA.
Yan et al. Page 17
Nature. Author manuscript; available in PMC 2019 January 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Extended Data Figure 5. X-ray Structure of holo-pDHAD and homology model of AstD
a, Superimpositions monomer of holo-pDHAD (PDB: 5ZE4, 2.11 Å) and RlArDHT (PDB: 
5J84). The holo structure containing the 2Fe-2S cofactor and Mg2+ ion in the active site. The 
structure of holo-pDHAD is in white; the crystal structure of RlArDHT is in cyan. b, 
Superimpositions of holo-pDHAD and homology modeled AstD. The structure of AstD was 
constructed by homology modeling based on the structure of holo-pDHAD. The structure of 
holo-pDHAD is in white; the crystal structure of AstD is in green. c, The electron density 
map of cofactors in the holo structure of pDHAD. White grid: 2Fo-Fc map at 1.2 σ level. 
Green grid: Fo-Fc positive map at 3.2σ level. Cyan sticks: acetic acid molecule. d, 
Comparison of the active sites in the crystal structure of pDHAD and the modeled structure 
of AstD. The cartoon represents superimposed binding sites of pDHAD (white) and AstD 
(green). The shift of a loop in AstD, where L518 (correspond to V496 in pDHAD) is 
located, coupled with a larger L198 residue (correspond to I177 in pDHAD) lead to a 
smaller hydrophobic pocket of AstD than that in pDHAD. e, The surface of binding sites of 
AstD (left) and pDHAD (right). The smaller hydrophobic channel in modeled AstD cannot 
accommodate the AA molecule (yellow balls-and-sticks).
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Extended Data Figure 6. Sequence alignment between pDHAD and AstD
The sequence identity between pDHAD and AstD is 56.8%, whereas the similarity between 
them is 75.0%. Residues were colored according to their property and similarity.
Extended Data Figure 7. Spray assay of AA on A. thaliana
Glufosinate resistant A. thaliana was treated with (right) or without (left) AA in the solvent, 
which is a commercial glufosinate based herbicide marketed as Finale®. To improve the 
wetting and penetration, AA was firstly dissolved in ethanol and then added to solvent (0.06 
g/L Finale® Bayer Inc. + 20 g/L ethanol) to make 250 μM AA spraying solution. The 
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control plants were treated with solvent containing ethanol only. Spraying treatments began 
upon the seeds germination, and were repeated once every two days with approximately 0.4 
mL AA solution per time per pot for 4 weeks. The picture shown below is taken after one 
month of treatment. The application rate of AA is approximately 1.6 lb/acre, which is 
comparable to the commonly used herbicide glyphosate (0.75~1.5 lb/acre). The experiments 
were repeated independently for 3 times with similar results.
Extended Data Figure 8. Specific inhibition of anther development in A. thaliana
Comparison of flower organs between the AA treated (a–c) and non-treated (d–f) 
Arabidopsis. a compare to d, the AA treated flower shows abnormal pistil elongation due to 
the lack of pollination. b compare to e, the AA treated flower is missing one stamen. c 
compare to f, the AA treated anther is depleted of healthy and mature pollen. The 
experiments were performed twice with similar results.
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Extended Data Figure 9. Schematic illustration of results from the cross experiment
a, Wild type A. thaliana treated with 250 μM AA was pollinated with pollen from the un-
treated plant that carries the glufosinate resistant gene. Offspring was obtained, and inherited 
the glufosinate resistance from the pollen donor. b, similar as in a, except that the pollen 
donor was also treated with 250 μM AA. No offspring was obtained from this cross. Similar 
results were obtained with the treatment of AA at 100 μM.
Extended Data Table 1
Data collection and refinement statistics (molecular replacement).
holo-pDHAD
Data collection
Space group P42212
Cell dimensions
 a, b, c (Å) 135.5, 135.5, 66.0
 α, β, γ (°) 90, 90, 90
Resolution (Å) 47.89-2.11 (2.15-2.11)*
Rsym or Rmerge 0.189 (1.240)
I/σI 17.86 (2.33)
Completeness (%) 100 (100)
Redundancy 25.1 (23.1)
Refinement
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holo-pDHAD
Resolution (Å) 95.79-2.11
No. reflections 33235 (1714)
Rwork/Rfree 0.1767/0.2216
No. atoms
 Protein 4208
 Ligand/ion 24
 Water 118
B-factors
 Protein 26.60
 Ligand/ion 46.53
 Water 26.22
R.m.s. deviations
 Bond lengths (Å) 0.007
 Bond angles (°) 1.195
*Values in parentheses are for highest-resolution shell.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Genome mining of a DHAD inhibitor and biosynthesis of aspterric acid (AA). a, Valine, 
leucine and isoleucine are produced by two parallel pathways using three enzymatic steps: 
ALS, KARI, and DHAD. b, A 17 kb gene cluster from A. terreus containing four ORFs, 
which are also conserved among several fungal species. AstA has sequence homology to 
sesquiterpene cyclase; AstB and AstC are predicted to be P450 monooxygenases; astD is 
predicted to encode a DHAD, and is proposed to confer self-resistance in the presence of the 
NP produced in the cluster. c, HPLC-MS traces of metabolites produced from S. cerevisiae 
RC01 expressing different ast genes under PADH2 promoter control. i: S. cerevisiae without 
expression plasmids. ii: S. cerevisiae transformed with plasmids expressing astA and astB 
produces 2. iii: S. cerevisiae transformed with plasmids expressing astA-C produces AA at a 
titer of 20 mg/L. The experiments were repeated independently with similar results for 3 
times. d, Proposed biosynthetic pathway of AA. AstA cyclizes farnesyl diphosphate (FPP) 
into (−)-daucane 1, while the P450 enzymes AstB and AstC sequentially transform 1 into 2 
and 3 (AA), respectively.
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Fig. 2. Aspterric acid (AA) is a plant growth inhibitor
a, 2-week old Arabidopsis thaliana growing on MS media containing no AA (left) or 50 μM 
AA (right). The picture shown is representative of 3 replicates. b, Same as in a, except for 2-
week old dicot Solanum lycopersicum and monocot Zea mays. The picture shown is 
representative of 2 replicates. c, Verification of the self-resistance function of AstD. Growth 
inhibition curve of AA on S. cerevisiae ΔILV3 strains expressing fungal housekeeping 
fDHAD (blue) or AstD (red) in isoleucine, leucine and valine (ILV) dropout media. The plot 
shows mean values ± s.d. (error bars); n = 3 biologically independent experiments. d, 
Crystal structure of the dimeric holo A. thaliana DHAD (pDHAD) containing the cofactor 
2Fe-2S cluster and a Mg2+ ion with the docked AA in the active site. One of the pDHAD 
monomers is show in cyan, whereas the other one is shown in electrostatic surface 
representation. The docked AA is shown in the inset in spaced-filled model. The 
hydrophobic portions of AA are surrounded by several hydrophobic residues (white spheres) 
from both monomers. e, Cross-section electrostatic map of modeled holo-pDHAD in the 
binding site. Red map: the normalized negatively charged regions; blue map: the normalized 
positively charged regions; white map: the hydrophobic regions. The docked AA in the 
active site of pDHAD is shown on the left, while the docked native substrate 
dihydroxyisovalerate is shown on the right. The docking studies suggest the hydrophobic 
entrance to the reaction chamber preferentially binds the bulkier, tricyclic AA.
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Fig. 3. 
AA-resistance of Arabidopsis plants expressing astD transgenes. a, Phenotype of 10-day old 
A. thaliana with (lower) and without (upper) astD transgene growing on media containing 
100 μM AA. Control plants were transformed with a vector that carries the glufosinate 
ammonium selection marker but no astD transgene. The picture shown is representative of 3 
replicates. b, Fresh weight of 3-week old Arabidopsis seedlings growing on media with (red 
box) and without (blue box) 100 μM AA; Box plots show the median and extend of the 1st to 
3rd quartile range, with individual data points overlaid; n = 21 biologically independent 
experiments. c, glufosinate-resistant Arabidopsis with (lower) and without (upper) astD 
transgene growing in soil were sprayed with glufosinate ammonium with (left) and without 
(right) 250 μM AA. i. control sprayed with 250 μM AA + glufosinate ammonium. ii. control 
sprayed with glufosinate ammonium only. iii. astD transgenic Arabidopsis sprayed with 250 
μM AA + glufosinate ammonium. iv. astD transgenic Arabidopsis sprayed with glufosinate 
ammonium only. The picture shown is representative of 3 replicates. d, Quantification of the 
height of Arabidopsis treated the same as in c; The plot shows mean values ± s.d. (error 
bars); n = 12 biologically independent experiments.
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